WATSON 415 (Estropipate 1.5 mg)
Pill imprint WATSON 415 has been identified as Estropipate 1.5 mg.
Estropipate is used in the treatment of postmenopausal symptoms; oophorectomy; osteoporosis; atrophic urethritis; hypoestrogenism (and more), and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not subject to the Controlled Substances Act.
See also related documents.